BMRN financial statements

The full income statement, balance sheet, and cash-flow statement for BioMarin Pharmaceutical Inc. (BMRN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 190.4M2024-09 190.6M2024-12 190.8M2025-03 191.8M2025-06 192.0M2025-09 192.1M2025-12 192.3M2026-03 193.3M2026-06 193.6M+1.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	3.22B YoY+12.9%	2.85B YoY+18.0%	2.42B YoY+15.4%	2.10B YoY+13.5%	1.85B YoY-0.8%
Cost of revenue	717M YoY+23.6%	580M YoY+9.1%	532M YoY+5.8%	503M YoY+6.9%	471M YoY-10.3%
Research & development	922M YoY+23.4%	747M YoY+0.1%	747M YoY+15.0%	650M YoY+3.3%	629M YoY+0.1%
Selling, general & administrative	1.15B YoY+14.3%	1.01B YoY+13.1%	892M YoY+8.4%	823M YoY+8.4%	759M YoY+2.9%
Amortization of intangibles	19.4M YoY-55.2%	43.3M YoY-30.5%	62.2M YoY-7.4%	67.2M	—
Operating income	409M YoY-15.4%	484M YoY+160.6%	186M YoY+15.4%	161M YoY+295.5%	-82.3M YoY-89.6%
Interest expense	10.9M YoY-14.0%	12.7M YoY-26.9%	17.3M YoY+8.5%	16.0M YoY+4.1%	15.3M YoY-47.7%
Interest & investment income	74.9M YoY+0.0%	74.9M YoY+28.4%	58.3M YoY+223.5%	18.0M YoY+72.0%	10.5M YoY-36.9%
Pre-tax income	482M YoY-10.9%	542M YoY+187.3%	189M YoY+26.1%	150M YoY+298.5%	-75.3M YoY-53.8%
Income tax	134M YoY+16.3%	115M YoY+449.3%	20.9M YoY+161.0%	8.02M YoY+171.1%	-11.3M YoY+98.8%
	349M YoY-18.3%	427M YoY+154.6%	168M YoY+18.4%	142M YoY+320.9%	-64.1M YoY-107.5%
Net income to common	349M YoY-18.3%	427M YoY+154.6%	168M YoY+18.4%	142M YoY+320.9%	-64.1M YoY-107.5%
	$1.80 YoY-18.6%	$2.21 YoY+154.0%	$0.87 YoY+16.0%	$0.75 YoY+314.3%	-$0.35 YoY-107.8%
EPS (basic)	$1.82 YoY-19.1%	$2.25 YoY+152.8%	$0.89 YoY+17.1%	$0.76 YoY+317.1%	-$0.35 YoY-107.4%
	192M YoY+0.9%	190M YoY+1.2%	188M YoY+1.4%	185M YoY+1.3%	183M YoY+1.1%
	197M YoY+0.3%	197M YoY+2.7%	192M YoY+1.4%	189M YoY+3.3%	183M YoY-4.6%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	3.95B YoY+22.3%	3.23B YoY+9.3%	2.96B YoY+7.4%	2.75B YoY+21.0%	2.27B YoY-2.9%
Cash & equivalents	1.31B YoY+39.1%	943M YoY+24.9%	755M YoY+4.2%	725M YoY+23.4%	587M YoY-9.5%
Accounts receivable	908M YoY+37.5%	661M YoY+4.2%	634M YoY+37.4%	461M YoY+23.5%	373M YoY-16.7%
Inventory	1.30B YoY+5.4%	1.23B YoY+11.3%	1.11B YoY+23.8%	894M YoY+15.1%	777M YoY+11.2%
Other current assets	186M YoY-7.8%	202M YoY+42.5%	141M YoY+35.3%	105M YoY-5.4%	110M YoY-15.0%
	7.59B YoY+8.7%	6.99B YoY+2.2%	6.84B YoY+7.3%	6.38B YoY+6.2%	6.00B YoY+2.7%
Property, plant & equipment	953M YoY-8.7%	1.04B YoY-2.2%	1.07B YoY-0.7%	1.07B YoY+3.7%	1.04B YoY+0.3%
Operating lease right-of-use	35.2M YoY+22.9%	28.7M YoY-32.9%	42.7M YoY+22.3%	34.9M YoY-8.5%	38.2M YoY-17.0%
Goodwill	196M YoY+0.0%	196M YoY+0.0%	196M YoY+0.0%	196M YoY+0.0%	196M YoY+0.0%
Intangible assets	214M YoY-16.2%	255M YoY-13.4%	295M YoY-13.0%	339M YoY-12.9%	389M YoY-6.9%
Deferred tax assets	1.51B YoY+1.3%	1.49B YoY-3.7%	1.55B YoY+2.7%	1.51B YoY+3.8%	1.45B YoY+1.3%
Other non-current assets	277M YoY+10.2%	251M YoY+46.6%	172M YoY-2.7%	176M YoY+15.9%	152M YoY+6.9%
	759M YoY+25.0%	607M YoY-48.4%	1.18B YoY+99.9%	589M YoY+7.8%	546M YoY+11.0%
Accrued liabilities	759M YoY+25.0%	607M YoY-11.1%	683M YoY+19.2%	573M YoY+15.0%	498M YoY+1.2%
Deferred revenue	—	1.37M YoY-70.4%	4.62M YoY+549.8%	711K YoY-89.8%	6.96M YoY+4476.3%
Short-term & current debt	0.00	—	—	—	—
Current lease liability	8.57M YoY+18.5%	7.23M YoY-16.3%	8.64M YoY+6.8%	8.09M YoY-1.3%	8.20M YoY-7.8%
Finance lease liability (current)	116K YoY-66.0%	341K YoY+145.3%	139K YoY-93.9%	2.29M YoY+0.9%	2.27M YoY-20.9%
	1.51B YoY+13.2%	1.33B YoY-29.6%	1.89B YoY+6.7%	1.77B YoY+1.9%	1.74B YoY-0.2%
Long-term debt	597M	—	—	—	—
Non-current lease liability	36.6M YoY+19.9%	30.5M YoY-19.8%	38.0M YoY+44.5%	26.3M YoY-17.4%	31.9M YoY-21.2%
Operating lease liability (total)	45.1M YoY+19.6%	37.7M YoY-19.2%	46.7M YoY+35.7%	34.4M YoY-14.1%	40.1M YoY-18.8%
Finance lease liability (total)	552K YoY-49.7%	1.10M YoY+407.9%	216K YoY-91.3%	2.47M YoY-41.5%	4.23M YoY-38.5%
Finance lease liability	436K YoY-42.3%	756K YoY+881.8%	77.0K YoY-58.2%	184K YoY-90.6%	1.96M YoY-51.1%
Other non-current liabilities	151M YoY+17.1%	129M YoY+7.4%	120M YoY+19.9%	100M YoY+1.7%	98.4M YoY-13.9%
	6.09B YoY+7.6%	5.66B YoY+14.3%	4.95B YoY+7.6%	4.60B YoY+7.9%	4.27B YoY+4.0%
Common stock	192K YoY+0.5%	191K YoY+1.1%	189K YoY+1.6%	186K YoY+1.1%	184K YoY+1.1%
Additional paid-in capital	5.96B YoY+2.7%	5.80B YoY+3.4%	5.61B YoY+3.8%	5.40B YoY+4.1%	5.19B YoY+4.0%
Retained earnings	154M YoY+179.2%	-195M YoY+68.7%	-622M YoY+21.2%	-789M YoY+15.2%	-931M YoY-8.0%
Accumulated other comprehensive income	-13.5M YoY-121.9%	61.7M YoY+314.2%	-28.8M YoY-644.5%	-3.87M YoY-126.8%	14.4M YoY+189.4%
Total liabilities & equity	7.59B YoY+8.7%	6.99B YoY+2.2%	6.84B YoY+7.3%	6.38B YoY+6.2%	6.00B YoY+2.7%
	192M YoY+0.8%	191M YoY+1.1%	189M YoY+1.3%	186M YoY+1.3%	184M YoY+1.2%
	192M YoY+0.8%	191M YoY+1.1%	189M YoY+1.3%	186M YoY+1.3%	184M YoY+1.2%
	192M YoY+0.8%	191M YoY+1.1%	189M YoY+1.2%	187M YoY+1.4%	184M YoY+1.2%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	828M YoY+44.5%	573M YoY+259.7%	159M YoY-9.5%	176M YoY-42.2%	305M YoY+256.7%
Depreciation & amortization	79.6M YoY-17.5%	96.4M YoY-7.6%	104M YoY+2.4%	102M YoY-5.6%	108M YoY+2.7%
Intangible amortization	19.4M YoY-55.2%	43.3M YoY-30.5%	62.2M YoY-7.4%	67.2M	—
Share-based compensation	181M YoY-10.0%	202M YoY-2.7%	207M YoY+5.5%	196M YoY-0.5%	197M YoY+4.0%
Deferred income taxes	48.7M YoY-13.1%	56.1M YoY+224.7%	-45.0M YoY+13.6%	-52.1M YoY-233.7%	-15.6M YoY+98.2%
Change in receivables	228M YoY+293.8%	57.9M YoY-69.6%	190M YoY+132.1%	82.0M YoY+225.1%	-65.6M YoY-211.1%
Change in inventory	117M YoY+84.1%	63.5M YoY-59.5%	157M YoY+130.1%	68.3M YoY+94.7%	35.1M YoY-42.7%
	-414M YoY-403.5%	136M YoY+222.7%	-111M YoY-455.4%	-20.0M YoY+94.5%	-366M YoY-583.2%
Capital expenditure	103M YoY+20.6%	85.4M YoY-11.7%	96.7M YoY-20.1%	121M YoY+26.6%	95.6M YoY-16.4%
Free cash flow	725M YoY+48.7%	487M YoY+679.0%	62.6M YoY+13.9%	54.9M YoY-73.7%	209M YoY+821.9%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Purchases of investments	356M YoY-13.3%	410M YoY-52.8%	868M YoY+42.0%	612M YoY-34.7%	937M YoY+76.9%
Sales/maturities of investments	338M YoY-46.6%	633M YoY-26.8%	865M YoY+39.5%	620M YoY-10.3%	691M YoY+24.3%
Other investing activities	0.00 YoY+100.0%	-1.14M	0.00	0.00 YoY-100.0%	994K YoY+37.5%
	-42.4M YoY+91.9%	-526M YoY-2711.2%	-18.7M YoY-0.4%	-18.6M YoY-38754.2%	-48.0K YoY-100.0%
Long-term debt issued	0.00	0.00	0.00	0.00	0.00
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00
Common stock issued	0.00	0.00	0.00	0.00	0.00
Common stock repurchased	0.00	0.00	0.00	0.00	0.00 YoY-100.0%
Dividends paid	0.00	0.00	0.00	0.00	0.00
Other financing activities	-889K YoY+72.0%	-3.18M YoY+73.0%	-11.8M YoY-351.5%	-2.60M YoY-554.5%	-398K
FX effect on cash	—	—	—	—	-57.0K YoY+95.0%
Net change in cash	369M YoY+96.5%	188M YoY+513.5%	30.6M YoY-77.7%	137M YoY+321.8%	-61.9M YoY-129.2%
Interest paid	7.25M YoY-30.1%	10.4M YoY+0.6%	10.3M YoY+0.2%	10.3M YoY-1.1%	10.4M YoY-14.6%
Income taxes paid	96.2M YoY+68.0%	57.3M YoY-21.9%	73.3M YoY+34.8%	54.4M YoY+199.5%	18.2M YoY+102.2%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	11.4B YoY-8.9%	12.5B YoY-31.0%	18.2B YoY-5.6%	19.2B YoY+18.3%	16.3B YoY+2.0%
P/E	32.8× YoY+11.5%	29.4× YoY-76.2%	123.5× YoY-46.1%	229.2×	—
P/S	3.5× YoY-19.2%	4.4× YoY-44.1%	7.9× YoY-17.9%	9.6× YoY+8.7%	8.8× YoY+2.8%
P/B	1.9× YoY-15.3%	2.2× YoY-40.2%	3.7× YoY-11.9%	4.2× YoY+10.5%	3.8× YoY-2.0%
P/FCF	15.8× YoY-38.7%	25.7× YoY-95.0%	517.4× YoY+78.3%	290.2× YoY+272.9%	77.8×
	3.1% YoY-10.3%	3.4% YoY+320.5%	0.81% YoY+85.5%	0.44%	—
	6.3% YoY+63.2%	3.9% YoY+1911.3%	0.19% YoY-43.9%	0.34% YoY-73.2%	1.3%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: BMRN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BMRN filings on SEC EDGAR → Not investment advice.